Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Japanese study of BMS-790052 plus BMS-650032 in chronic hepatitis C genotype 1b non-responders and IFN-ineligible/intolerant patients
jRCT2080221687Phase 3
- Sponsor
- Bristol Myers Squibb
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of daclatasvir and asunaprevir in chronic hepatitis C (CHC), sponsored by Bristol Myers Squibb.
02
Drugs
daclatasvirasunaprevir
03
Conditions
chronic hepatitis C (CHC)
Beyond the preview
Go deeper on jRCT2080221687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221687.